Zomedica stock

zomedica stock

Is zomedica stock a high-growth meme stock?

ZOM stock surged earlier this year alongside other high-growth meme names, to nearly $3 per share. To put this in context, Zomedicas share price started the year at the $0.35 level. Currently, however, the stock trades at around $0.50 apiece.

What is the ticker symbol for zomedica?

Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol ZOM. Who are Zomedicas major shareholders? Zomedicas stock is owned by a number of retail and institutional investors.

Is zomedica efficiently growing its dividend?

Zomedica does not have a long track record of dividend growth. In the past three months, Zomedica insiders have bought more of their companys stock than they have sold. Specifically, they have bought $112,500.00 in company stock and sold $0.00 in company stock.

Is zomedica back to square one?

Closing at 69 cents per share on Aug. 26, you could say Zomedica (NYSEAMERICAN: ZOM) is getting back to square one. Shares in this pet health care play saw stunning performance earlier this year, when ZOM stock became one of many penny stocks sent “to the moon” by retail traders.

Are meme stocks zomedica and Zom stock turning green?

In recent days, meme stocks have turned green in a big way. Shares of GameStop (NYSE: GME) and AMC Entertainment (NYSE: AMC) are both up big over the past week. Investors in Zomedica (NYSE: ZOM) and ZOM stock appear to be riding these coattails.

Is zomedica (Zom) stock headed for $1?

Today, social media is exploding with interest in ZOM stock as it shoots 20% higher. Some retail traders think Zomedica is headed for the $1 level in short order. As a highly shorted stock, Zomedica is a company that is in the crosshairs of short-squeeze speculators.

Why is Zom stock soaring today?

Indeed, ZOM stock has surged from under 50 cents per share this time last week to as high as 67 cents today. This move has been driven, at least in part, by surging retail investor interest. Today, social media is exploding with interest in ZOM stock as it shoots 20% higher.

Is zomedica losing its luster?

Accordingly, its hard to look at Zomedicas recent results positively. Zomedica is a company that has lost its luster, at least in terms of being considered a meme stock. Any sort of positive momentum the company had earlier this year appears to have waned.

Since then, ZOM stock has increased by 41.2% and is now trading at $0.2935. View which stocks have been most impacted by COVID-19. When is Zomedicas next earnings date?

What is zomedica Corps market cap?

What price target have analysts set for ZOM? 1 equities research analysts have issued 12-month price targets for Zomedicas shares. Their forecasts range from $0.30 to $0.30. On average, they anticipate Zomedicas share price to reach $0.30 in the next year.

Where is zomedica based?

Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan. IDXX: IDEXX Laboratories vs. Zomedica: Which Pet Stock is a Better Investment for 2022?

Is zomedica stock a buy below $1?

The last time I wrote about Zomedica (NYSEAMERICAN: ZOM) was on March 22. At the time, I said ZOM stock was an excellent long-term buy for speculative investors. Since then, ZOM stock has lost 57% of its value. As I write this, it’s trading well below $1.

Why did zomedica switch to a direct sales organization?

Here’s why. On April 15, Zomedica announced it was moving to a direct sales organization, phasing out its distributor-based sales efforts. “As TRUFORMA ®’s market presence grew, we intended to transition from a distributor-based sales model to a direct sales organization.

What happened to zomedica?

InvestorPlace’s Vince Martin wrote an article on April 9 that points to the company’s past financial troubles and what it had to do to extricate itself from the mess. Zomedica, close to bankruptcy in 2019, entered into a financial arrangement with a Michigan-based real estate investment fund.

Is Zom stock on a downward slide?

While a change in its sales approach hasn’t helped boost investor confidence, the reality is that ZOM stock has been on a downhill slide since it launched its Truforma diagnostic platform two weeks early in mid-March.

Postagens relacionadas: